Page last updated: 2024-11-05

thiotepa and Cancer of the Fallopian Tube

thiotepa has been researched along with Cancer of the Fallopian Tube in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research Excerpts

ExcerptRelevanceReference
"Thiotepa (45 mg) was instilled into the chest cavity and medroxyprogesterone (100 mg tid) and melphalan (6 mg/d for 4 days over 6 weeks) were given."1.26Primary carcinoma of the fallopian tube. ( Kadziora, MB; Srinivasan, R, 1981)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kadziora, MB1
Srinivasan, R1

Other Studies

1 other study available for thiotepa and Cancer of the Fallopian Tube

ArticleYear
Primary carcinoma of the fallopian tube.
    Canadian journal of surgery. Journal canadien de chirurgie, 1981, Volume: 24, Issue:4

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Hu

1981